Hogan Lovells has advised ESAB Corporation on its acquisition of EWM GmbH. ESAB Corporation, a global leader in industrial fabrication technology, has announced the signing of...
ESAB Corporation to Acquire EWM GmbH in €275 Million Deal
Harmony Biosciences Holdings’ Acquisition of Zynerba Pharmaceuticals
Hogan Lovells acted as legal counsel for Harmony Biosciences Holdings, Inc. Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies...
Labcorp’s Strategic Laboratory Agreement With Ascension
Hogan Lovells advised Labcorp on the deal while Jones Day represented Ascension. Labcorp, a leading global life sciences company, signed an agreement to create a comprehensive...
Ciena Corporation’s $400 Million Notes Offering
Cahill represented the initial purchasers in the offering. Hogan Lovells advised Ciena Corporation. Ciena Corporation (NYSE: CIEN) (“Ciena”) executed a private offering of $400 million in...
LabCorp’s US$1 Billion Senior Notes Offering
Hogan Lovells represented LabCorp on the deal. The offering consisted of US$500 million aggregate principal amount of 1.550% Senior Notes due 2026 and $500 million aggregate...